Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Bosentan Therapy for Pulmonary Arterial Hypertension
20022.0k citationsLewis J. Rubin, David B. Badesch et al.New England Journal of Medicineprofile →
Predicting Survival in Pulmonary Arterial Hypertension
20101.1k citationsRaymond L. Benza, Dave P. Miller et al.Circulationprofile →
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
20011.1k citationsRichard N. Channick, Olivier Sitbon et al.profile →
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial
20021.1k citationsGérald Simonneau, Robyn J. Barst et al.American Journal of Respiratory and Critical Care Medicineprofile →
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
20021.0k citationsAdaani Frost et al.The Journal of Heart and Lung Transplantationprofile →
Pulmonary Arterial Hypertension
2009866 citationsDavid B. Badesch, C. Gregory Elliott et al.CHEST Journalprofile →
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008785 citationsNazzareno Galiè, Horst Olschewski et al.Circulationprofile →
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015750 citationsNazzareno Galiè, Joan Albert Barberà et al.New England Journal of Medicineprofile →
An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
2012737 citationsRaymond L. Benza, Dave P. Miller et al.CHEST Journalprofile →
Sitaxsentan Therapy for Pulmonary Arterial Hypertension
2003540 citationsRobyn J. Barst, David Langleben et al.American Journal of Respiratory and Critical Care Medicineprofile →
Updated Treatment Algorithm of Pulmonary Arterial Hypertension
2013489 citationsNazzareno Galiè, Adaani Frost et al.Journal of the American College of Cardiologyprofile →
Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension
2006454 citationsVallerie V. McLaughlin, Ronald J. Oudiz et al.American Journal of Respiratory and Critical Care Medicineprofile →
Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
2013411 citationsMarius M. Hoeper, Robyn J. Barst et al.Circulationprofile →
Predicting Survival in Patients With Pulmonary Arterial Hypertension
2019390 citationsRaymond L. Benza, Mardi Gomberg‐Maitland et al.CHEST Journalprofile →
The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension
2011389 citationsRaymond L. Benza, Mardi Gomberg‐Maitland et al.CHEST Journalprofile →
Five-Year Outcomes of Patients Enrolled in the REVEAL Registry
2015337 citationsHarrison W. Farber, Dave P. Miller et al.CHEST Journalprofile →
Diagnosis of pulmonary hypertension
2018297 citationsAdaani Frost, David B. Badesch et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Adaani Frost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adaani Frost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adaani Frost more than expected).
This network shows the impact of papers produced by Adaani Frost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adaani Frost. The network helps show where Adaani Frost may publish in the future.
Co-authorship network of co-authors of Adaani Frost
This figure shows the co-authorship network connecting the top 25 collaborators of Adaani Frost.
A scholar is included among the top collaborators of Adaani Frost based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Adaani Frost. Adaani Frost is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Galiè, Nazzareno, Joan Albert Barberà, Adaani Frost, et al.. (2015). Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. New England Journal of Medicine. 373(9). 834–844.750 indexed citations breakdown →
Hoeper, Marius M., Robyn J. Barst, Robert C. Bourge, et al.. (2013). Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension. Circulation. 127(10). 1128–1138.411 indexed citations breakdown →
9.
Benza, Raymond L., Dave P. Miller, Mardi Gomberg‐Maitland, et al.. (2010). Predicting Survival in Pulmonary Arterial Hypertension. Circulation. 122(2). 164–172.1139 indexed citations breakdown →
Simonneau, G., Leona J. Rubin, Nazzareno Galiè, et al.. (2009). Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: A randomized trial (Annals of Internal Medicine (2008) 149, (521-530)). Annals of Internal Medicine. 151(6).106 indexed citations
12.
Galiè, Nazzareno, Horst Olschewski, Ronald J. Oudiz, et al.. (2008). Ambrisentan for the Treatment of Pulmonary Arterial Hypertension. Circulation. 117(23). 3010–3019.785 indexed citations breakdown →
13.
McLaughlin, Vallerie V., Ronald J. Oudiz, Adaani Frost, et al.. (2006). Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 174(11). 1257–1263.454 indexed citations breakdown →
Barst, Robyn J., David Langleben, Adaani Frost, et al.. (2003). Sitaxsentan Therapy for Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 169(4). 441–447.540 indexed citations breakdown →
Simonneau, Gérald, Robyn J. Barst, Nazzareno Galiè, et al.. (2002). Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine. 165(6). 800–804.1052 indexed citations breakdown →
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.